| NCT ID | NCT05425615 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical College of Wisconsin |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 135 participants |
| Start Date | 2024-06-05 |
| Primary Completion | 2032-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 135 participants in total. It began in 2024-06-05 with a primary completion date of 2032-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will examine the effect of TMS on people with stroke and aphasia as well as healthy individuals.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with left hemisphere stroke * Consent date \>= 1 month after stroke onset * Right-handed * Fluent in English * 18 years of age or older Exclusion Criteria: * Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing * Non-decisional per decisionality questionnaire or other clinical assessment * Presence of major untreated or unstable psychiatric disease (e.g. schizophrenia, bipolar disease) * A chronic medical condition that is not treated or is unstable * Presence of 1. cardiac stimulators or pacemakers or intracardiac lines 2. neurostimulators 3. medication infusion device 4. any other implants near the scalp (e.g., cochlear implants) or in the eye 5. metal in the body * Pregnancy * History of skull fractures, or skin diseases * History of ongoing or unmanaged seizures or a family history of epilepsy * Presence of factors that potentially decrease seizure thresholds * On pro-convulsant medications * Untreated Sleep deprivation or insomnia * Ongoing alcoholism or illegal drug abuse (e.g., cocaine or MDMA users) * History of dyslexia or other developmental learning disabilities
Contact & Investigator
Priyanka Shah-Basak, PhD
PRINCIPAL INVESTIGATOR
Medical College of Wisconsin
Frequently Asked Questions
Who can join the NCT05425615 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05425615 currently recruiting?
Yes, NCT05425615 is actively recruiting participants. Contact the research team at sschoenrock@mcw.edu for enrollment information.
Where is the NCT05425615 trial being conducted?
This trial is being conducted at Milwaukee, United States.
Who is sponsoring the NCT05425615 clinical trial?
NCT05425615 is sponsored by Medical College of Wisconsin. The principal investigator is Priyanka Shah-Basak, PhD at Medical College of Wisconsin. The trial plans to enroll 135 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.